Janux Therapeutics, Inc. (JANX)
13.15
-0.61
(-4.43%)
USD |
NASDAQ |
Jan 20, 16:00
13.15
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Total Liabilities (Quarterly): 48.21M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| MannKind Corp. | 539.19M |
| Madrigal Pharmaceuticals, Inc. | 736.72M |
| Editas Medicine, Inc. | 188.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Shareholders Equity (Quarterly) | 976.56M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 35.86 |
| Net Debt Paydown Yield | 0.02% |